Literature DB >> 20945336

Imaging of apoptosis in the heart with nanoparticle technology.

Howard H Chen1, Lee Josephson, David E Sosnovik.   

Abstract

Apoptosis plays an important role in the loss of cardiomyocytes in both ischemic injury and heart failure. Pioneering work with single photon emission computed tomography imaging of (99)Tc-annexin showed that cell death in the heart could be imaged in vivo. Over the last 5 years a significant amount of experience with annexin-labeled magnetic nanoparticles, principally AnxCLIO-Cy5.5, has also been gained. Here, we review the experience with AnxCLIO-Cy5.5 in the heart and compare this experience to that of earlier studies with (99)Tc-annexin. The imaging of apoptosis with AnxCLIO-Cy5.5 provides valuable insights not only into molecular imaging in the heart but, more broadly, into the use of nanoparticle technology for molecular imaging in general. (c) 2010 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 20945336      PMCID: PMC3086683          DOI: 10.1002/wnan.115

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol        ISSN: 1939-0041


  51 in total

1.  Internalization of annexin A5-functionalized iron oxide particles by apoptotic Jurkat cells.

Authors:  Geralda A F van Tilborg; Tessa Geelen; Hans Duimel; Paul H H Bomans; Peter M Frederik; Honorius M H F Sanders; Niko M Deckers; Roel Deckers; Chris P M Reutelingsperger; Gustav J Strijkers; Klaas Nicolay
Journal:  Contrast Media Mol Imaging       Date:  2009 Jan-Feb       Impact factor: 3.161

2.  Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging.

Authors:  Anne M Neubauer; Jacob Myerson; Shelton D Caruthers; Franklin D Hockett; Patrick M Winter; Junjie Chen; Patrick J Gaffney; J David Robertson; Gregory M Lanza; Samuel A Wickline
Journal:  Magn Reson Med       Date:  2008-11       Impact factor: 4.668

3.  Conquering the dark side: colloidal iron oxide nanoparticles.

Authors:  Angana Senpan; Shelton D Caruthers; Ilsu Rhee; Nicholas A Mauro; Dipanjan Pan; Grace Hu; Michael J Scott; Ralph W Fuhrhop; Patrick J Gaffney; Samuel A Wickline; Gregory M Lanza
Journal:  ACS Nano       Date:  2009-12-22       Impact factor: 15.881

4.  Feasibility of concurrent dual contrast enhancement using CEST contrast agents and superparamagnetic iron oxide particles.

Authors:  Assaf A Gilad; Hanneke W M van Laarhoven; Michael T McMahon; Piotr Walczak; Arend Heerschap; Michal Neeman; Peter C M van Zijl; Jeff W M Bulte
Journal:  Magn Reson Med       Date:  2009-04       Impact factor: 4.668

5.  Molecular MRI of cardiomyocyte apoptosis with simultaneous delayed-enhancement MRI distinguishes apoptotic and necrotic myocytes in vivo: potential for midmyocardial salvage in acute ischemia.

Authors:  David E Sosnovik; Elisabeth Garanger; Elena Aikawa; Matthias Nahrendorf; Jose-Luiz Figuiredo; Guangping Dai; Fred Reynolds; Anthony Rosenzweig; Ralph Weissleder; Lee Josephson
Journal:  Circ Cardiovasc Imaging       Date:  2009-09-29       Impact factor: 7.792

6.  Molecular MRI detects low levels of cardiomyocyte apoptosis in a transgenic model of chronic heart failure.

Authors:  David E Sosnovik; Matthias Nahrendorf; Peter Panizzi; Takashi Matsui; Elena Aikawa; Guangping Dai; Ling Li; Fred Reynolds; Gerald W Dorn; Ralph Weissleder; Lee Josephson; Anthony Rosenzweig
Journal:  Circ Cardiovasc Imaging       Date:  2009-09-01       Impact factor: 7.792

7.  In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging.

Authors:  Ulrich Flögel; Zhaoping Ding; Hendrik Hardung; Sebastian Jander; Gaby Reichmann; Christoph Jacoby; Rolf Schubert; Jürgen Schrader
Journal:  Circulation       Date:  2008-06-23       Impact factor: 29.690

Review 8.  Cell death.

Authors:  Richard S Hotchkiss; Andreas Strasser; Jonathan E McDunn; Paul E Swanson
Journal:  N Engl J Med       Date:  2009-10-15       Impact factor: 91.245

9.  99mTc-labeled duramycin as a novel phosphatidylethanolamine-binding molecular probe.

Authors:  Ming Zhao; Zhixin Li; Scott Bugenhagen
Journal:  J Nucl Med       Date:  2008-07-16       Impact factor: 10.057

Review 10.  Targeted imaging of myocardial damage.

Authors:  David E Sosnovik; Matthias Nahrendorf; Ralph Weissleder
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-08
View more
  8 in total

Review 1.  Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 2: Radiolabeled Probes.

Authors:  John C Stendahl; Albert J Sinusas
Journal:  J Nucl Med       Date:  2015-08-20       Impact factor: 10.057

2.  Protective effect of the apoptosis-sensing nanoparticle AnxCLIO-Cy5.5.

Authors:  Howard H Chen; Yan Feng; Ming Zhang; Wei Chao; Lee Josephson; Stanley Y Shaw; David E Sosnovik
Journal:  Nanomedicine       Date:  2011-06-24       Impact factor: 5.307

3.  Highly potent visnagin derivatives inhibit Cyp1 and prevent doxorubicin cardiotoxicity.

Authors:  Aarti Asnani; Baohui Zheng; Yan Liu; You Wang; Howard H Chen; Anita Vohra; An Chi; Ivan Cornella-Taracido; Huijun Wang; Douglas G Johns; David E Sosnovik; Randall T Peterson
Journal:  JCI Insight       Date:  2018-01-11

4.  Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase.

Authors:  Yan Liu; Aarti Asnani; Lin Zou; Victoria L Bentley; Min Yu; You Wang; Graham Dellaire; Kumar S Sarkar; Matthew Dai; Howard H Chen; David E Sosnovik; Jordan T Shin; Daniel A Haber; Jason N Berman; Wei Chao; Randall T Peterson
Journal:  Sci Transl Med       Date:  2014-12-10       Impact factor: 17.956

Review 5.  Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives.

Authors:  Natasha Manners; Vishnu Priya; Abhishesh Kumar Mehata; Manoj Rawat; Syam Mohan; Hafiz A Makeen; Mohammed Albratty; Ali Albarrati; Abdulkarim M Meraya; Madaswamy S Muthu
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-01

Review 6.  Personalized Management of Cardiovascular Disorders.

Authors:  Kewal K Jain
Journal:  Med Princ Pract       Date:  2017-09-11       Impact factor: 1.927

Review 7.  Annexins in Glaucoma.

Authors:  Timothy E Yap; Benjamin Michael Davis; Li Guo; Eduardo M Normando; Maria Francesca Cordeiro
Journal:  Int J Mol Sci       Date:  2018-04-17       Impact factor: 5.923

8.  Comparative Assessment of Silver Nanocomposites' Biological Effects on the Natural and Synthetic Matrix.

Authors:  Mikhail A Novikov; Eugeniy A Titov; Larisa M Sosedova; Viktor S Rukavishnikov; Vera A Vokina; Oleg L Lakhman
Journal:  Int J Mol Sci       Date:  2021-12-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.